Meridian Bioscience (VIVO) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.74 -9.75%
Financial Fact:
Common share options: -897K
Today's EPS Names:
CRMT, REPL, HURC, More
Financial Fact:
Common share options: -897K
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q2 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $50.2 million versus the consensus estimate of $51.74 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Are we witnessing a fundamental or speculative rally in the S&P 500?
- C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
- Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
